PHI (Prostate Health Index) as a predictor of positive biopsy in prostate cancer: Results from multicentric study
Abstrakt
n our multicentric study we confirmed that PHI is generally stronger predictor for positive biopsy than PSA (PHI AUC 70,725). We can also conclude that PHI has better predictive ability and correlations with number of positive cores than PSA in rebiopsy.